about
Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic StrategiesNutrigenomic analysis of diet-gene interactions on functional supplements for weight managementPharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.The pharmacological treatment and management of obesity.Anti-obesity action of gingerol: effect on lipid profile, insulin, leptin, amylase and lipase in male obese rats induced by a high-fat diet.Complementary and alternative medicine for the treatment of obesity: a critical reviewIschemic colitis after mesotherapy combined with anti-obesity medications.Behavioral and pharmacologic therapies for obesity.Weight-gain in psychiatric treatment: risks, implications, and strategies for prevention and management.Lifestyle modification in the management of the metabolic syndrome: achievements and challenges.Piloting a new approach to the treatment of obesity using dexamphetamine.Mechanisms responsible for excess weight loss after bariatric surgeryDesipramine inhibits histamine H1 receptor-induced Ca2+ signaling in rat hypothalamic cells.New targets to treat obesity and the metabolic syndrome.Efficacy and tolerability of an herbal formulation for weight management.Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice.Appetite suppressants, cardiac valve disease and combination pharmacotherapyCurrent pharmacotherapeutic concepts for the treatment of obesity in adults.Managing the combination of nonalcoholic fatty liver disease and metabolic syndrome.Advances in medical therapy for weight loss and the weight-centric management of type 2 diabetes mellitus.Prevalence, pathophysiology, health consequences and treatment options of obesity in the elderly: a guideline.Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension.Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment--a position paper of the The Obesity Society and The American Society of Hypertension.Metabolic improvement of morbid obese patients following Roux-en-Y gastric bypass surgery: A prospective study in Mashhad, Iran.Gastric electrical stimulation parameter dependently alters ventral medial hypothalamic activity and feeding in obese rats.Food intake and body weight responses to intermittent vs. continuous gastric electrical stimulation in diet-induced obese rats.Key factors involved in obesity development.
P2860
Q28088325-5C42F179-31E6-49D0-97E2-D615B3EC9A2EQ28388787-0317735B-728C-44BF-A64A-BBA454A2A535Q30366778-D1A0E175-8841-4DA6-AAD8-59CE44BD7FC1Q30399340-272C320D-76D8-4A81-A6F1-CF462FB63EAFQ33461026-837DA6AB-D70F-40FA-87EE-ACDF055AA4ECQ33686271-AE80B86D-DAE0-4DE3-8CA1-7BD906B3ECECQ33756309-A03316DE-BB66-445C-9F98-BB31A4D94847Q34543656-9AAE1795-4D8F-40D7-B3AD-5A9ACAA1CE43Q34543946-DF825601-338A-47FE-B5A5-27512186E5C2Q34620622-69E89967-57B9-42A6-9D6A-D69BB4BA8FEDQ35063613-880BCD92-598F-4937-AD26-56BFC077626DQ35529693-994843AC-B3D4-4F96-858E-73A9D00A2A76Q35918173-836CA3D1-147F-4EF0-96AB-51C0990C8060Q36068914-30237A84-6881-4343-9D39-4C46F08A6034Q36933466-D54635D4-4137-4780-AD2C-683896883509Q36956106-85D66DAF-2325-45F7-BF48-F6B5BEB5345AQ37268774-D0580993-6B2A-43E0-A76B-3DF38FF3E6C1Q37368688-AB412F4A-4122-47BD-BDAC-2D8414ADC114Q37951502-1F0B0589-DA75-4F68-B724-90DA60435DF3Q37960391-563F48D2-4A76-4C39-8EE9-35B178AA9F40Q38026444-97CB1D0F-AC47-46D9-91B9-BACCBAD7E782Q38071133-75661EE9-EF76-490D-83F4-1FF846BE4340Q38080812-AD7C7CDF-4E21-43EF-84E1-535A8222A222Q42107859-D8AC63BB-BC69-4194-981A-9A44CD6ADD27Q42493169-B6BC1953-EBA5-461B-83D4-F683C489BBF8Q47283679-D865D307-EE7C-42A1-B6F1-66B92A467673Q47755607-4EC1FC9E-68FE-43EF-867E-C042938B8334
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Drug treatment of the overweight patient.
@en
type
label
Drug treatment of the overweight patient.
@en
prefLabel
Drug treatment of the overweight patient.
@en
P1433
P1476
Drug treatment of the overweight patient.
@en
P2093
Donna H Ryan
P304
P356
10.1053/J.GASTRO.2007.03.053
P407
P577
2007-05-01T00:00:00Z